Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.

  • Published 1981 in Federal register
The Food and Drug Administration [FDA] is amending the biologics regulations to make clear that an active plasmapheresis donor, who is to be immunized for the production of high-titer plasma, does not need to be reexamined before the first immunization injection if the same donor has previously received a physical examination for plasmapheresis in… CONTINUE READING